Events

Events

On-Demand Webinar: Improved Models of Multiple Sclerosis to Accelerate Pipelines

Multiple Sclerosis (MS) is a chronic, demyelinating disease affecting ~2.3 million patients worldwide, with few effective treatments. There is a critical need for therapies that promote remyelination.

Watch this recorded webinar to hear experts from Renovo Neural discuss their classical and novel animal models to assess neurodegeneration and remyelination. 

In this 30-minute session, you’ll learn:

  • How you can leverage in vivo models developed at Renovo Neural: Augmented Cuprizone Models for Remyelination and Neuroprotection.
  • How you can obtain quantitative and qualitative assessment of both white and grey matter, as included in Renovo Neural’s histological services.
  • How to accelerate and enhance proof-of-concept testing in your drug development programs.

 

About Our Speaker

        Renovo Neural


J. Simon Lunn, PhD, serves as Director of Laboratory Operations at Renovo Neural. He has focused his career on understanding and promoting regeneration of the nervous system. During his postdoctoral training at the University of Michigan, Dr. Lunn studied the potential use of growth factor and stem cell therapeutics to treat amyotrophic lateral sclerosis (ALS). His experience in neural regeneration gives him a unique perspective on an approach to treat or even cure multiple sclerosis.  Dr. Lunn earned a B.Sc. in Biochemistry from the University of Glasgow, and his PhD at the University of Dundee to understand the signaling mechanisms responsible for establishment of the early neural plate.

ABOUT THE AUTHOR
author

Chandreyee Das

Senior Content Manager

Chandreyee Das, Ph.D. (Chemical Biology, UCSF) is a Senior Content Manager at Science Exchange with 15 years of research experience and 10 years of life science content marketing experience. Chandreyee was a Fulbright Scholar and won fellowships from the U.S. NSF and NIH. Following postdoctoral research at Dana-Farber Cancer Institute, she worked at MilliporeSigma, delivering scientific content to life science tools customers. She has published in both peer-reviewed and industry news outlets.

Leave a Reply

Your email address will not be published.